Teriparatide biosimilar (Zydus Cadila)

特立帕肽生物类似药（Zydus Cadila）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTeriparatide biosimilar (Zydus Cadila)

Drug Alias Name特立帕肽生物仿制药（Zydus Cadila）Teriparatida (Zydus Cadila)Teriparatidum (Zydus Cadila)Recombinant parathyroid hormone biosimilar (Zydus Cadila)rhPTH (1-34) (Zydus Cadila)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionParathyroid hormone replacements

TargetsParathyroid hormone receptor

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsOsteoporosis

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2014/01/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesZydus Cadila

China Registration ClassN/A

Develop Information

Active CompaniesZydus Cadila

Inactive CompaniesN/A

Active IndicationsOsteoporosis

Inactive IndicationsN/A

Other Information

ATC CodeH05AA02